Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

893 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Acarbose bioequivalence: Exploration of eligible protocol design.
Que L, Huang K, Ding Y, Chu N, Yang J, Qian Z, He Q. Que L, et al. Among authors: chu n. J Clin Pharm Ther. 2021 Apr;46(2):492-503. doi: 10.1111/jcpt.13313. Epub 2020 Dec 16. J Clin Pharm Ther. 2021. PMID: 33325562 Clinical Trial.
Comparative Pharmacokinetics, Safety, and Immunogenicity Study of the Prefilled Syringe and Lyophilized Formulation of a Recombinant Human Tumor Necrosis Factor-α Receptor II:lgG Fc Fusion Protein in Healthy Chinese Male Subjects.
Huang K, Chu N, Ding Y, Que L, Qian Z, Shi Y, Qin W, He Q. Huang K, et al. Among authors: chu n. Clin Pharmacol Drug Dev. 2022 Sep;11(9):1116-1123. doi: 10.1002/cpdd.1091. Epub 2022 Apr 13. Clin Pharmacol Drug Dev. 2022. PMID: 35419986 Clinical Trial.
Safety, Tolerability, and Pharmacokinetic Study of 101BHG-D01 Nasal Spray, a Novel Long-Acting and Selective Cholinergic M Receptor Antagonist, in Healthy Chinese Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Escalation, First-In-Human Study.
Chu NN, Huang K, Que LL, Ding Y, Gu XH, Zhang L, Wang JK, Chen XP, Sun ZG, He Q. Chu NN, et al. Eur J Drug Metab Pharmacokinet. 2022 Jul;47(4):509-521. doi: 10.1007/s13318-022-00769-6. Epub 2022 Apr 16. Eur J Drug Metab Pharmacokinet. 2022. PMID: 35429285 Clinical Trial.
A Randomized, Double-Blind, Single-Dose Study Comparing the Biosimilarity of HOT-1010 With Bevacizumab (Avastin®) in Chinese Healthy Male Subjects.
Huang K, Que L, Ding Y, Chu N, Qian Z, Shi Y, Qin W, Li Z, Chen Y, Gu X, Wang J, Zhang L, Zhang J, Zhu X, Yang Y, Tang Y, He Q. Huang K, et al. Among authors: chu n. Front Pharmacol. 2021 Jun 17;12:694375. doi: 10.3389/fphar.2021.694375. eCollection 2021. Front Pharmacol. 2021. PMID: 34220519 Free PMC article.
893 results